Hualan Biological Engineering Inc. (SHE:002007)

SHE:002007 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	4,254	4,366	5,333	4,503	4,426	5,016
Other Revenue	13.58	13.58	8.9	13.67	10.31	7.09
Revenue	4,267	4,379	5,342	4,517	4,436	5,023
Revenue Growth (YoY)	-13.26%	-18.02%	18.26%	1.82%	-11.69%	35.76%
Cost of Revenue	1,864	1,768	1,727	1,699	1,538	1,405
Gross Profit	2,404	2,611	3,615	2,818	2,898	3,618
Selling, General & Admin	993.77	1,066	1,465	1,205	1,011	1,328
Research & Development	355.91	333.18	280.84	314.7	253.63	213.21
Other Operating Expenses	67.21	38.35	44.62	41.75	36.17	37.29
Operating Expenses	1,431	1,432	1,805	1,595	1,312	1,621
Operating Income	972.53	1,179	1,810	1,223	1,586	1,997
Interest Expense	-7.96	-12.95	-13.17	-30.27	-21.72	-4.97
Interest & Investment Income	126.42	157.95	164.47	128.92	85.28	100.8
Currency Exchange Gain (Loss)	-0.15	-0.15	-0.3	-0.01	0.33	0.3
Other Non Operating Income (Expenses)	-12.85	-0.49	-0.28	-0.38	-0.34	-0.44
EBT Excluding Unusual Items	1,078	1,323	1,961	1,322	1,650	2,093
Gain (Loss) on Sale of Investments	26.65	32.94	60.54	36.11	26.86	25.96
Gain (Loss) on Sale of Assets	0.52	0.08	44.44	47.67	0.42	-0.26
Asset Writedown	6.57	-5.71	-9.71	-1.19	-3.23	-0.62
Other Unusual Items	0.52	-11.81	21.24	24.17	14.39	29.33
Pretax Income	1,112	1,339	2,078	1,428	1,688	2,147
Income Tax Expense	140.25	183.14	315.96	180.76	234.13	303.21
Earnings From Continuing Operations	972.01	1,155	1,762	1,248	1,454	1,844
Minority Interest in Earnings	-23.39	-67.62	-280.11	-171.34	-155.22	-231.06
Net Income	948.62	1,088	1,482	1,076	1,299	1,613
Net Income to Common	948.62	1,088	1,482	1,076	1,299	1,613
Net Income Growth	-29.10%	-26.57%	37.66%	-17.14%	-19.48%	25.69%
Shares Outstanding (Basic)	1,827	1,826	1,824	1,825	1,821	1,818
Shares Outstanding (Diluted)	1,827	1,829	1,824	1,828	1,831	1,820
Shares Change (YoY)	-0.16%	0.23%	-0.19%	-0.17%	0.59%	0.13%
EPS (Basic)	0.52	0.60	0.81	0.59	0.71	0.89
EPS (Diluted)	0.52	0.59	0.81	0.59	0.71	0.89
EPS Growth	-28.98%	-26.75%	37.92%	-17.00%	-19.95%	25.52%
Free Cash Flow	1,104	803.92	592.43	563.36	621.15	703.85
Free Cash Flow Per Share	0.60	0.44	0.33	0.31	0.34	0.39
Dividend Per Share	0.700	0.200	0.300	0.300	0.200	0.300
Dividend Growth	133.33%	-33.33%	-	50.00%	-33.33%	-2.50%
Gross Margin	56.33%	59.62%	67.67%	62.38%	65.33%	72.03%
Operating Margin	22.79%	26.92%	33.89%	27.08%	35.76%	39.76%
Profit Margin	22.23%	24.84%	27.73%	23.83%	29.28%	32.11%
Free Cash Flow Margin	25.87%	18.36%	11.09%	12.47%	14.00%	14.01%
EBITDA	1,233	1,439	2,069	1,496	1,783	2,179
EBITDA Margin	28.90%	32.86%	38.74%	33.12%	40.18%	43.38%
D&A For EBITDA	260.84	260.07	259.05	272.5	196.39	181.66
EBIT	972.53	1,179	1,810	1,223	1,586	1,997
EBIT Margin	22.79%	26.92%	33.89%	27.08%	35.76%	39.76%
Effective Tax Rate	12.61%	13.68%	15.21%	12.65%	13.87%	14.12%
Revenue as Reported	4,267	4,379	5,342	4,517	4,436	5,023
Advertising Expenses	-	5.08	6.31	2.84	3.38	2.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.